Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To compare the effects of six-month versus longer regimens for abdominal tuberculosis (TB), consisting of a two-month intensive phase with rifampicin, isoniazid, pyrazinamide, and ethambutol followed by a four-month or longer continuation phase including at least isoniazid and rifampicin.
| Original language | English |
|---|---|
| Article number | CD012163 |
| Pages (from-to) | CD012163 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2016 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1 Nov 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Six-month therapy for abdominal tuberculosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver